Skip to main content
CELLULAR GOODS PLC logo

CELLULAR GOODS PLC — Investor Relations & Filings

Ticker · CBX ISIN · GB00BK964W87 LEI · 213800IXPX4Z2MKX2U28 IL Manufacturing
Filings indexed 232 across all filing types
Latest filing 2021-04-12 Board/Management Inform…
Country GB United Kingdom
Listing IL CBX

About CELLULAR GOODS PLC

https://cellular-goods.com/

Cellular Goods PLC is a wellness company focused on developing consumer products using lab-grown, biosynthetic cannabinoids. The company's initial product lines included high-end skincare and topical athletic recovery solutions, utilizing cannabinoids like Cannabidiol (CBD) produced via cellular agriculture. This method aims to provide high-purity and sustainable ingredients. In early 2024, the company announced a strategic shift to focus on artificial intelligence applications within the beauty sector, leading to a proposed name change to Cel AI PLC.

Recent filings

Filing Released Lang Actions
Cellular Goods boosts team with five appointments
Board/Management Information Classification · 99% confidence The document begins with an 'RNS Number' and is dated April 12, 2021. The content announces the appointment of five new team members (Head of Process and Applied Sciences, senior hires, and expert consultants) to support product development and strategy. This is a corporate announcement regarding personnel changes, specifically senior management/board-related hires, which aligns with the definition of 'Board/Management Information' (MANG). Although it is distributed via RNS, the content itself is not a mandatory regulatory filing like a 10-K or a general regulatory notice (RNS), but a specific announcement about management structure changes. The document length is moderate (6345 chars), suggesting it is the primary content, not just a brief announcement of a report (ruling 2 does not apply). Therefore, MANG is the most appropriate classification.
2021-04-12 English
Second Price Monitoring Extn
Regulatory Filings Classification · 99% confidence The document is very short (1933 characters) and contains the header 'RNS Number : 6488R'. It announces a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange. This is a general regulatory announcement concerning trading status rather than a specific financial report (like 10-K, IR, or ER). Since it is a general regulatory announcement provided via RNS, and it doesn't fit into the more specific categories like DIRS, DIV, or CAP, the most appropriate classification is the general Regulatory Filings category (RNS).
2021-03-09 English
Price Monitoring Extension
Regulatory Filings Classification · 99% confidence The document is very short (1916 characters) and contains the header 'RNS Number : 6477R'. It announces a 'Price Monitoring Extension' for a security, which is a specific, short-form operational update related to trading mechanisms on the London Stock Exchange. It explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This type of brief, operational regulatory announcement that doesn't fit into specific financial reporting categories (like 10-K, ER, or IR) is best classified as a general Regulatory Filing (RNS). It is not a report itself, nor is it a dividend notice, management change, or earnings release.
2021-03-09 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is very short (1933 characters) and contains the header 'RNS Number : 9014Q'. It announces a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange. It explicitly states that the information is provided by RNS, the news service of the London Stock Exchange, which is approved as a Primary Information Provider. This type of short, immediate regulatory update that doesn't fit a specific financial reporting category (like 10-K, ER, or IR) is best classified as a general Regulatory Filing or announcement, which corresponds to the RNS code.
2021-03-02 English
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document is very short (1916 characters) and contains the header 'RNS Number : 9004Q' and mentions 'RNS, the news service of the London Stock Exchange' and 'Financial Conduct Authority'. The content itself is a brief announcement regarding a 'Price Monitoring Extension' for a security, which is a specific operational notice related to trading rather than a comprehensive financial report or a standard regulatory filing like 10-K or ER. Since it is a general regulatory announcement that doesn't fit the specific categories (like DIV, DIRS, ER, etc.), the most appropriate classification is the general regulatory filing fallback category, RNS.
2021-03-02 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document contains an 'RNS Number' and explicitly states it is provided by 'RNS, the news service of the London Stock Exchange,' which is approved as a Primary Information Provider. The content describes a 'Second Price Monitoring Extension' related to trading activity, which is a specific type of market announcement. While RNS is the source, the content itself is a regulatory/market announcement that doesn't fit the specific definitions for 10-K, ER, DIV, etc. Given the context of being a general regulatory news service announcement from the LSE, and lacking a more specific category, the most appropriate classification is the general Regulatory Filings category (RNS). The document length is short (1933 chars), but it is the announcement itself, not an announcement *of* another report, so RPA is less suitable than RNS for this specific market operational notice.
2021-03-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.